Citation only
via OpenAlex
Senescent Cell Heterogeneity and Precision Clearance Strategies: From Molecular Mechanism to Clinical Translation
Integrative Biomedical Research · 2026
Abstract
Cellular senescence(definition), an essentially irreversible growth arrest first described in cultured fibroblasts, is now recognized as a druggable driver of multiple age-related diseases, yet clinical progress has been slowed by the marked heterogeneity of senescent cells across tissues, inducing stressors, and disease states. We conducted a structured narrative synthesis of peer-reviewed literature senescence biology, single-cell senotyping, and senotherapeutic development, following informed search and appraisal strategy across PubMed/MEDLINE, Scopus, and Web of Science. Sixty-plus primary and review sources were synthesized into four evidence tables spanning first-generation agents, precision platforms, multi-tissue biomarkers, and human trials. First-generation senolytics(definition) (dasatinib plus quercetin, fisetin, navitoclax) demonstrate proof-of-concept efficacy but are constrained by dose-limiting toxicities, whereas next-generation platforms—PROTAC degraders, uPAR-directed CAR-T cells, senolytic vaccines, and galactose-caged prodrugs—achieve markedly higher predicted selectivity with lower off-target risk, operating through convergent mechanistic nodes upstream of tissue-level inflammaging(definition). Early-phase human trials corroborate target engagement but remain underpowered for definitive efficacy claims. Precision senotherapy is mechanistically justified and clinically nascent; its translational success will depend on resolving the biomarker bottleneck and matching senotype-specific vulnerabilities to intervention class.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.25163/biomedical.10110880
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Patel, R., & Sahu, Y. (2026). Senescent Cell Heterogeneity and Precision Clearance Strategies: From Molecular Mechanism to Clinical Translation. <em>Integrative Biomedical Research</em>. https://doi.org/10.25163/biomedical.10110880
Vancouver
Patel R, Sahu Y. Senescent Cell Heterogeneity and Precision Clearance Strategies: From Molecular Mechanism to Clinical Translation. Integrative Biomedical Research. 2026. doi:10.25163/biomedical.10110880.
BibTeX
@article{ragini2026Senesc,
title = {Senescent Cell Heterogeneity and Precision Clearance Strategies: From Molecular Mechanism to Clinical Translation},
author = {Ragini Patel and Yogendra Sahu},
journal = {Integrative Biomedical Research},
year = {2026},
doi = {10.25163/biomedical.10110880},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2026
Preprint · OA
Decoding and Targeting Coordinated CDKN1A and CDKN2A Senescence Programs in ECM-Dominant Cardiovascular Pathologies
The Journal of Prevention of Alzheimer s Disease 2021
Open access · CC-BY
Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial
GeroScience 2022
Preprint · OA
Spatial transcriptomic analysis reveals inflammatory foci defined by senescent cells in the white matter, hippocampi and cortical grey matter in the aged mouse brain
Veterinary Pathology 2020
Citation only
Cellular Senescence: Mechanisms, Morphology, and Mouse Models
Nature 2025
Open access · CC-BY
Single-cell transcriptomic and genomic changes in the ageing human brain
Nature Communications 2026
Open access · CC-BY